Orally inhaled flecainide favorable for conversion of atrial fibrillation to sinus rhythm: Insights from INSTANT phase 2 trial
USA: Findings from the INSTANT phase 2 trial showed that orally inhaled flecainide passed muster for converting atrial fibrillation (AF) to sinus rhythm. The findings were published online in JACC: Clinical Electrophysiology on April 10, 2024. INSTANT was an open-label, multicenter, single-arm study of flecainide acetate oral inhalation solution (FlecIH) for acute conversion of recent-onset […]